VOYA INVESTMENT MANAGEMENT LLC - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$12,000
-93.2%
104,3720.0%0.00%
Q3 2018$177,000
-2.7%
104,3720.0%0.00%
Q2 2018$182,000
-4.7%
104,3720.0%0.00%
Q1 2018$191,000
-18.0%
104,3720.0%0.00%
Q4 2017$233,000
-23.1%
104,3720.0%0.00%
-100.0%
Q3 2017$303,000
-34.7%
104,3720.0%0.00%0.0%
Q2 2017$464,000
+35.7%
104,372
+42.3%
0.00%0.0%
Q1 2017$342,000
-23.5%
73,3470.0%0.00%0.0%
Q4 2016$447,000
+10.6%
73,3470.0%0.00%0.0%
Q3 2016$404,000
+44.8%
73,3470.0%0.00%0.0%
Q2 2016$279,000
+121.4%
73,347
+60.4%
0.00%
Q1 2016$126,000
-51.4%
45,7180.0%0.00%
-100.0%
Q4 2015$259,000
+7.0%
45,7180.0%0.00%0.0%
Q3 2015$242,000
-48.6%
45,718
-19.4%
0.00%0.0%
Q2 2015$471,000
+65.3%
56,697
-8.2%
0.00%0.0%
Q1 2015$285,000
+51.6%
61,7420.0%0.00%
Q4 2014$188,000
+9.3%
61,7420.0%0.00%
Q3 2014$172,000
-31.5%
61,7420.0%0.00%
-100.0%
Q2 2014$251,000
-23.5%
61,7420.0%0.00%0.0%
Q1 2014$328,000
-5.7%
61,7420.0%0.00%0.0%
Q4 2013$348,000
+23.4%
61,7420.0%0.00%0.0%
Q3 2013$282,000
+5.6%
61,7420.0%0.00%0.0%
Q2 2013$267,00061,7420.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2015
NameSharesValueWeighting ↓
Alpine Partners USVI, LLC 152,500$697,0002.61%
Trellus Management Company, LLC 155,800$712,0000.90%
WALL STREET ASSOCIATES 942,200$4,306,0000.40%
BAILARD, INC. 340,500$1,556,0000.30%
Baker Brothers Advisors 2,608,271$11,920,0000.17%
STONERIDGE INVESTMENT PARTNERS LLC 104,158$476,0000.10%
Cambridge Investment Research Advisors, Inc. 449,080$2,052,0000.09%
BTG Pactual Global Asset Management Ltd 33,700$154,0000.03%
HighTower Advisors, LLC 242,001$1,106,0000.03%
BHF Kleinwort Benson Group S.A. 39,000$178,0000.02%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders